A Single-center, Randomized, Double-blind, Placebo-controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Oral Doses of OPC 39436 Spray-dry Tablets in Healthy Elderly Subjects

Trial Profile

A Single-center, Randomized, Double-blind, Placebo-controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Oral Doses of OPC 39436 Spray-dry Tablets in Healthy Elderly Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Aug 2017

At a glance

  • Drugs OPC 39436 (Primary)
  • Indications Neurological disorders
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 08 Aug 2017 Status changed from active, no longer recruiting to completed.
    • 22 Aug 2016 Status changed from recruiting to active, no longer recruiting.
    • 16 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top